chartexchange

KALA
KALA BIO, Inc. Common Stock
stockNASDAQ

At CloseNov 13, 2026 3:50:22 PM EST
0.14USD-1.873%(-0.00)23,289
Pre-marketNov 16, 2026 9:20:30 AM EST
3.77USD+2616.138%(+3.63)
After-hoursNov 13, 2026 4:43:30 PM EST
0.1425USD+4.626%(+0.0063)
3.2500Bid4.7600Ask1.5100Spread
Loading…
Loading…
Healthcare
Drug Manufacturers-Specialty & Generic
CEO
Mark Iwicki
HQ
Arlington, MA, USA
Previous Close
$0.14
Beta
2.73
52-Week High
$95.50 2025-12-01
52-Week Low
$0.11 2026-10-14
SMA 50
$0.33
SMA 200
$5.32
Avg. Vol 10D
261,079
Avg. Vol 30D
378,956
Avg. Vol 90D
1.13M
Relative Vol
0.06
644,659
18.59M
2883.32%
12.9700%
29,972
Nov 18, 2026 (2d)
May 11, 2026 · 1-for-50 (reverse)
Nov 12, 2026
Nov 9, 2026
KALA Profile

kala pharmaceuticals, inc. (kala) is a biopharmaceutical company focused on the development and commercialization of therapeutics using our proprietary nanoparticle-based mucus penetrating particles, or mpp, technology, with an initial focus on the treatment of eye diseases. for more information, please visit kala's website at www.kalarx.com.

KALA Performance
PeriodPriceDateChangeBeta
1W0.182026-11-09+1880.26%4.598
1M0.192026-10-16+1748.87%3.222
3M0.912026-08-17+285.74%3.742
6M2.932026-05-15+19.83%2.821
1Y34.952025-11-17-89.95%2.726
2Y335.002024-11-15-98.95%—
5Y5,394.612021-11-16-99.94%1.141
KALA Stock Summary

KALA BIO, Inc. Common Stock (NASDAQ:KALA) stock price today is $3.51, and today's volume is 22,793. KALA is up 2429.539% today. The 30 day average volume is 378,956. KALA market cap is $2.26M with 644,659 shares outstanding.